GSK_ Annual_Report_2021-22

67 Particulars No. of shares issued (of ` 10 each) Year of issue Shares issued pursuant to the amalgamation of SmithKline Beecham Pharmaceuticals (India) Limited (SBPIL) with the Company in the ratio of one share of the Company for every two shares of SBPIL issued on 30 November 2001. 1,47,00,000 2001 Shares issued pursuant to the amalgamation of Burroughs Wellcome (India) Limited (BWIL) with the Company in the ratio of fourteen shares of the Company for every ten shares of BWIL issued on 29 October 2004 1,28,47,546 2004 Buy back of equity shares (26,19,529) 2005 Bonus Issue 8,47,03,017 2018 Total 16,94,06,034 List of top ten shareholders of the Company other than Glaxo Group Limited, GlaxoSmithKline Pte Limited, Eskaylab Limited and Burroughs Wellcome International Limited who hold 35.99%, 28.10%, 6.94% and 3.97% shares respectively are as follows: Sr. No. Name of Shareholder % to Equity 1 Life Insurance Corporation of India & Funds 4.54 2 Aditya Birla Sun Life Trustee Private Limited & Funds 3.19 3 General Insurance Corporation of India 1.42 4 Investor Education and Protection Fund Authority 0.54 5 ICICI Prudential Funds 0.49 6 Vanguard Emerging Markets Stock Index Fund, A Series 0.34 7 Vanguard Total International Stock Index Fund 0.33 8 The New India Assurance Company Limited 0.23 9 PGIM India Trustees Private Limited A/C PGIM India 0.19 10 IShares Core Emerging Markets Mauritius Co 0.18 Total 11.45 The distribution of shareholding as on 31 March 2022 is as follows: Category (Shares) No. of Holders % To Holders No. of Shares % To Equity Upto 25 43410 37.95 405211 0.24 26 to 50 13685 11.96 560765 0.33 51 to 100 15256 13.34 1293078 0.76 101 to 500 35160 30.74 8644184 5.10 501 to 1000 4510 3.94 3209888 1.90 1001 to 10000 2257 1.97 4739243 2.80 10001 and above 118 0.10 150553665 88.87 Total: 114396 100.00 169406034 100.00 Shareholding pattern as on 31 March 2022 is as follows: Category No. of Shares % Promoter and Promoter Group — Glaxo Group Limited, U.K. 60,970,500 35.99 — GlaxoSmithKline Pte Limited, Singapore 47,604,024 28.10 — Eskaylab Limited, U.K. 11,760,000 6.94 — Burroughs Wellcome International Limited, U.K. 6,720,000 3.97